X T L Biopharmaceuticals logo

X T L Biopharmaceuticals Share Price (NASDAQ: XTLB)

$1.23

Last updated on

Check the interactive X T L Biopharmaceuticals Stock chart to analyse performance

X T L Biopharmaceuticals Ltd Key Stats

Check X T L Biopharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.23
Open
$1.11
Market Capitalization
$10.8M
Today's Volume
$5.9K
Revenue TTM
$451.0K
EBITDA
$-2.0M
Earnings Per Share (EPS)
$-0.31
Profit Margin
-227.72%
Quarterly Earnings Growth YOY
-0.76%
Return On Equity TTM
-26.83%

Stock Returns calculator for X T L Biopharmaceuticals Stock including INR - Dollar returns

The X T L Biopharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

X T L Biopharmaceuticals investment value today

Current value as on today

₹50,175

Returns

₹49,825

(-49.83%)

Returns from X T L Biopharmaceuticals Stock

₹55,109 (-55.11%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards X T L Biopharmaceuticals Stock

-65%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for X T L Biopharmaceuticals Stock from India on INDmoney has decreased by -65% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in X T L Biopharmaceuticals Ltd

  • Name

    Holdings %

  • Noked Israel Ltd

    2.26%

  • Citadel Advisors Llc

    0.29%

  • Morgan Stanley - Brokerage Accounts

    0.15%

  • Rhumbline Advisers

    0.12%

Analyst Recommendation on X T L Biopharmaceuticals Stock

Rating
Trend

X T L Biopharmaceuticals Share Price Target

What analysts predicted

Upside of 2339.02%

Target:

$30.00

Current:

$1.23

X T L Biopharmaceuticals share price target is $30.00, a slight Upside of 2339.02% compared to current price of $1.23 as per analysts' prediction.

X T L Biopharmaceuticals Stock Insights

  • Price Movement

    In the last 1 year, XTLB stock has moved down by -55.9%
  • XTLB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 125.8%
  • XTLB vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 132.9%
  • Price to Sales

    ForXTLB every $1 of sales, investors are willing to pay $11.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

X T L Biopharmaceuticals Technicals Summary

Sell

Neutral

Buy

X T L Biopharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

X T L Biopharmaceuticals Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
X T L Biopharmaceuticals Ltd logo
-11.51%
-12.29%
-55.11%
-22.52%
-32.79%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About X T L Biopharmaceuticals Ltd

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.
Organization
X T L Biopharmaceuticals
Employees
10
CEO
Mr. Noam Band
Industry
Health Technology

Key Management of X T L Biopharmaceuticals Ltd

NameTitle
Mr. Noam Band
Chief Executive Officer
Mr. Itay Weinstein CPA
Chief Financial Officer

Important FAQs about investing in XTLB Stock from India :

What is X T L Biopharmaceuticals share price today?

X T L Biopharmaceuticals share price today is $1.23 as on at the close of the market. X T L Biopharmaceuticals share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for X T L Biopharmaceuticals share?

X T L Biopharmaceuticals share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. X T L Biopharmaceuticals stock price today i.e. is closed at $1.23, lower by 55.91% versus the 52 week high.

How to invest in X T L Biopharmaceuticals Stock (XTLB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for X T L Biopharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in X T L Biopharmaceuticals Shares that will get you 1.2195 shares as per X T L Biopharmaceuticals share price of $1.23 per share as on August 29, 2025 at 9:52 pm IST.

What is the minimum amount required to buy X T L Biopharmaceuticals Stock (XTLB) from India?

Indian investors can start investing in X T L Biopharmaceuticals (XTLB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in X T L Biopharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on X T L Biopharmaceuticals share’s latest price of $1.23 as on August 29, 2025 at 9:52 pm IST, you will get 8.1301 shares of X T L Biopharmaceuticals. Learn more about fractional shares .

What are the returns that X T L Biopharmaceuticals has given to Indian investors in the last 5 years?

X T L Biopharmaceuticals stock has given -32.79% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?